Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6868130 | 0.78 | RAB9A (0.40) | CTSDKDM4EALDH1A1 | |
| SCHEMBL28177103 | 0.75 | — | — | |
| SCHEMBL4438789 | 0.72 | — | — | |
| SCHEMBL9502640 | 0.72 | — | — | |
| SCHEMBL5349924 | 0.72 | — | — | |
| SCHEMBL10778535 | 0.70 | CA2 (0.43) | CTSDKDM4EALDH1A1 | |
| SCHEMBL1758555 | 0.70 | CTSD (0.44) | CTSDKDM4EALDH1A1 | |
| SCHEMBL10783525 | 0.69 | — | — | |
| SCHEMBL4525171 | 0.68 | — | — | |
| SCHEMBL4655048 | 0.68 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6566034-B2 | High contrast, containing novel type of nucleating agent | AGFA-GEVAERT (BE) | 2003-05-20 | — | — | US | disclosed |
| US-20020058195-A1 | Photographic material containing a novel hydrazine type | AGFA-GEVAERT (BE) | 2002-05-16 | — | — | US | disclosed |
| EP-1186946-A1 | Photographic material containing a novel hydrazine type | Agfa-Gevaert (BE) | 2002-03-13 | — | — | EP | disclosed |
| US-4595535-A | Schizophrenia | CIBA-GEIGY CORPORATION (US) | 1986-06-17 | — | — | US | disclosed |
| US-4073784-A | Certain as-triazino 4,3-a! 1,4!benzodiazepine-1,2-dione compounds | THE UPJOHN COMPANY (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058195-A1 | Photographic material containing a novel hydrazine type | ZKSCAN2, GPX1, ZP1 | CTSD 813/4885KDM4E 1492/4885ALDH1A1 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.